SH PHARMA (02607): Mao Jianyi Resigns from Vice President Position

Stock News

Sep 25, 2025

SH PHARMA (02607) announced that on September 25, 2025, the company's board of directors received a written resignation letter from Mr. Mao Jianyi. Due to work transfer arrangements, Mr. Mao Jianyi has resigned from his position as Vice President of the company. The resignation letter takes effect from the date of its delivery to the company's board of directors. Following his resignation, Mr. Mao Jianyi will no longer serve as Vice President of the company, but will continue to serve as Chairman of the subsidiary companies Shanghai Shangyao Xinyi Pharmaceutical Factory Co., Ltd. and Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1119547937"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1119547937\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1119547937?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-25 18:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119547937","market":"nz","top_or_hot":-1,"title":"SH PHARMA (02607): Mao Jianyi Resigns from Vice President Position","media":"Stock News","content":"<p>SH PHARMA (02607) announced that on September 25, 2025, the company's board of directors received a written resignation letter from Mr. Mao Jianyi. Due to work transfer arrangements, Mr. Mao Jianyi has resigned from his position as Vice President of the company. The resignation letter takes effect from the date of its delivery to the company's board of directors. Following his resignation, Mr. Mao Jianyi will no longer serve as Vice President of the company, but will continue to serve as Chairman of the subsidiary companies Shanghai Shangyao Xinyi Pharmaceutical Factory Co., Ltd. and Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SH PHARMA (02607): Mao Jianyi Resigns from Vice President Position</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSH PHARMA (02607): Mao Jianyi Resigns from Vice President Position\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-25 18:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SH PHARMA (02607) announced that on September 25, 2025, the company's board of directors received a written resignation letter from Mr. Mao Jianyi. Due to work transfer arrangements, Mr. Mao Jianyi has resigned from his position as Vice President of the company. The resignation letter takes effect from the date of its delivery to the company's board of directors. Following his resignation, Mr. Mao Jianyi will no longer serve as Vice President of the company, but will continue to serve as Chairman of the subsidiary companies Shanghai Shangyao Xinyi Pharmaceutical Factory Co., Ltd. and Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0175","symbol_name":"白马股","start_time":0,"source_url":"","article_id":"1119547937","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119547937","pubTimestamp":1758797180,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"SH PHARMA (02607) announced that on September 25, 2025, the company's board of directors received a written resignation letter from Mr. Mao Jianyi. Due to work transfer arrangements, Mr. Mao Jianyi...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK0175":"白马股","BK0012":"证金概念","BK0196":"行业龙头","BK0187":"一线龙头","BK0184":"上海国资改革","BK0097":"医药电商","BK0099":"上海本地重组","BK0209":"零售","BK1197":"保健护理产品经销商","BK0028":"国家队","BK0188":"融资融券","BK0020":"浦东新区","BK0183":"MSCI概念","02607":"上海医药"},"translate_title":"上海医药(02607)：毛建一辞去副总裁职务","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"02607":1},"content_text":"SH PHARMA (02607) announced that on September 25, 2025, the company's board of directors received a written resignation letter from Mr. Mao Jianyi. Due to work transfer arrangements, Mr. Mao Jianyi has resigned from his position as Vice President of the company. The resignation letter takes effect from the date of its delivery to the company's board of directors. Following his resignation, Mr. Mao Jianyi will no longer serve as Vice President of the company, but will continue to serve as Chairman of the subsidiary companies Shanghai Shangyao Xinyi Pharmaceutical Factory Co., Ltd. and Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}